Zura Bio Limited
ZURA
Last
$4.00
Day
-3.1%
1y
-8.4%
5y
-43.0%
52w
-44.5%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1233d
EMA 21
4.42
EMA 50
4.83
EMA 200
4.83
20d high
-22.9%
5y high
-89.0%
5y range
9th
Positions held
Your positionsZURA isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
1
Hold
watch
Signal
Neutral
Target
$4.67
Stop
$3.68
Stop distance
8.0%
Target vs last
+16.8%
Fundamentals
| Market cap | $395.77M | Enterprise value | $190.64M | Trailing P/E | — | Forward P/E | -6.72 |
| PEG | — | Price / book | 2.00 | Beta | 0.01 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -51.0% | ROA | -31.2% | Debt / equity | — |
| Current ratio | 12.90 | Free cash flow | -$48.82M | Analyst recommendation | strong_buy | Mean target | $18.00 |
| 52w high | $7.44 | 52w low | $3.15 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$26.3M | -$24.2M | -$17.2M | -$18.0M | -$16.0M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$29.3M | -$25.5M | -$18.4M | -$19.5M | -$18.1M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — |
| Net income | -$68.7M | -$52.4M | -$60.4M | -$25.7M |
| Gross margin | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | -$75.2M | -$55.2M | -$62.6M | -$27.2M |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-07 · This biotech stock is a top pick at Guggenheim
2026-09-11 · Zura Bio (ZURA) Hits Enrollment Milestones As Losses Widen Sharply
2026-08-31 · Zura Bio to Participate in the Cantor Global Healthcare Conference
2026-08-21 · Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-08-11 · Wedbush Adjusts Zura Bio Price Target to $22 From $15, Maintains Outperform Rating
Price (daily)
Full chart · RSI · MACD · patternsZURA · daily-8.4% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin